Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Sierra Bancorp (NASDAQ: BSRR) Executive Sells $382,091 in Stock, Signals Changes

Sierra Bancorp executed a significant stock sale worth $382,091 in late May. This action coincides with the company’s forthcoming participation in a major banking conference, stirring curiosity among investors. The transaction may reflect both strategic financial planning by executives and their outlook on the …

Vinay Lochav | 28 July 2026

Sportsman's Warehouse (NASDAQ:SPWH) Unveils a 2026 Turnaround Plan: Can Inventory Discipline Bring Shoppers Back?

Sportsman's Warehouse (NASDAQ:SPWH) Holdings posted a 2.1% same-store sales gain and a leaner inventory position for the thirteen weeks ended May 2, 2026, even as the outdoor-gear retailer widened its net loss slightly and leaned harder on its revolving credit line. Management calls it …

Nitish Kishor | 28 July 2026

Houthi Actions Weigh on Standard Chartered (OTC: SCBFF) Amidst Oil Price Turbulence

Standard Chartered's (OTC: SCBFF) shares fell 0.2% to $27.97 as oil prices dipped amid the Houthi maritime blockade impacting Saudi Arabia. The situation complicates global oil supply routes, raising concerns for the financial outlook of the company and investors alike.Key HighlightsStandard Chartered shares dropped …

Vinay Lochav | 28 July 2026

SS Innovations (NASDAQ:SSII) Revenue Jumps 117% as Robotic Surgeries Pass 11,000

SS Innovations (NASDAQ:SSII) International reported first-quarter 2026 revenue of $11.1 million, up 116.8% from a year earlier, as its SSi Mantra surgical robot extended its installed base in India and a handful of other markets. Cumulative procedures on the platform have since climbed past …

Nitish Kishor | 28 July 2026

TransUnion (NYSE: TRU) Raises 2026 Revenue Growth Guidance After Strong Q2

TransUnion's second-quarter results reveal a robust adjusted EPS of $1.23, surpassing the consensus estimate of $1.18. This performance, marked by a 15% revenue increase, signals healthy demand in a challenging environment, prompting the company to raise its full-year guidance.Key HighlightsTransUnion's Q2 revenue reached $1,310 …

Vinay Lochav | 28 July 2026

Strategy (NASDAQ:MSTR) Holds 843,775 Bitcoin and Builds a $3.2 Billion Cash Buffer: Is MSTR Entering a New Treasury Era?

Strategy Inc (NASDAQ:MSTR), the Nasdaq-listed company formerly known as MicroStrategy, disclosed in a Form 8-K filed July 20, 2026 that it now holds 843,775 bitcoin and maintains a $3.225 billion cash reserve earmarked for preferred dividends and note interest. The filing, read alongside a …

Nitish Kishor | 28 July 2026

US National Debt Hits $39.64T; Kiyosaki's Precious Metals Predictions Loom

The recent commentary from Robert Kiyosaki has drawn attention to the scale of the United States’ fiscal obligations. Kiyosaki argues that the government’s money‑creation practices, he says roughly $1 trillion each quarter, could precipitate a broader financial shift, prompting investors to consider assets that …

Vinay Lochav | 28 July 2026

Ohio Valley Banc Corp (NASDAQ: OVBC) Posts Q2 Net Income of $2.93M

Ohio Valley Banc Corp (NASDAQ: OVBC) reported a consolidated net income of $2,927,000 for the quarter ending June 30, 2026, marking a significant 30.5% drop from the prior year. This downturn comes despite an overall increase in earnings per share, which now stands at …

Vinay Lochav | 28 July 2026

Peoples Bancorp (NASDAQ: PEBO) Executive Sells $19,935 of Stock

Peoples Bancorp saw one of its top executives, Hugh J Donlon, move nearly $20,000 of equity out of personal holdings, a transaction that immediately caught the eye of investors tracking insider activity. The company, a key player in the Canadian regional banking space, now …

Vinay Lochav | 28 July 2026

Senti Biosciences (NASDAQ:SNTI) Charts a Pivotal Path for SENTI-202 Through a Spin-Off: Can Smart Cell Therapy Redefine Blood-Cancer Care?

Senti Biosciences Holdings, Inc. (NASDAQ:SNTI) said on May 14, 2026 that positive FDA feedback cleared a path toward a single-arm pivotal trial for SENTI-202, its logic-gated CAR-NK cell therapy for relapsed/refractory acute myeloid leukemia. Two months later, on July 15, 2026, the biotech disclosed …

Nitish Kishor | 28 July 2026
Support

Hi! How can we help you today?

Loading…